Objective: This retrospective post-hoc analysis of observational studies assesses the frequency of painful physical symptoms (PPS) in patients with major depressive disorder (MDD) of varied severity as may be seen in clinical practice. Methods: Observational studies of MDD that collected a clinician-reported measure of depression severity and included assessment of PPS were screened for this individual patient-level analysis. Six observational studies were included that enrolled outpatients with a diagnosis of MDD (assessed using the 17-item Hamilton depression scale, Hospital Anxiety and Depression Scale-Depression, or Inventory of Depressive Symptomatology). Measures of PPS were based on the original study assessment (modified Somatic Symptom Inventory [SSI] and Visual Analogue Scale [VAS]). Patients were divided into analysis cohorts based on the presence or absence of PPS. To model PPS status, odds ratios were calculated from logistic regression for cross-sectional analysis (main analysis) and generalized linear mixed models for longitudinal models (exploratory longitudinal analysis). Results: For the main analysis, four studies (N = 2943, 71.6% female, mean age 45.3 years) were identified. Of 2901 eligible patients, 61.7% were classified as having painful physical symptoms (PPS+). At study entry, 73.1% (957/1309) of patients in the severe category of depression, 56.8% (537/945) of those with moderate depression, and 45.6% (295/647) of those with mild depression were PPS+. The exploratory longitudinal analysis was performed using a subset (N = 2430) from the studies used in the main analysis plus two others (an additional 7984 patients, 6742 of which were modeled). The likelihood of patients that were PPS- at baseline later developing PPS was 5% to 13% greater for patients with increased depression severity (P<0.001) and the likelihood of PPS+ patients later not having PPS was 9% to 17% less for patients with increased depression severity (P<0.0001). Conclusions: Since this is a retrospective aggregate analysis of several observational studies, and due to missing data, care should be taken in the interpretation of these results. Despite the use of adjustment techniques, selection bias and unmeasured confounding may still be an issue for comparative analysis as not all variables were collected for all studies. For patients treated in typical care settings, PPS were associated with depression severity. However, patients with mild and moderate depression also exhibited PPS. Clinicians should be aware that PPS are present, and may warrant treatment, across depression severities.
机构:
Calif State Univ Fresno, Dept Psychol, Fresno, CA 93740 USACalif State Univ Fresno, Dept Psychol, Fresno, CA 93740 USA
Miller, Chris H.
Davis, Elena G.
论文数: 0引用数: 0
h-index: 0
机构:
Stanford Univ, Dept Psychol, Stanford, CA 94305 USACalif State Univ Fresno, Dept Psychol, Fresno, CA 93740 USA
Davis, Elena G.
King, Lucy S.
论文数: 0引用数: 0
h-index: 0
机构:
Stanford Univ, Dept Psychol, Stanford, CA 94305 USACalif State Univ Fresno, Dept Psychol, Fresno, CA 93740 USA
King, Lucy S.
Sacchet, Matthew D.
论文数: 0引用数: 0
h-index: 0
机构:
Stanford Univ, Dept Psychol, Stanford, CA 94305 USA
Stanford Univ, Sch Med, Stanford Neurosci Inst, Stanford, CA 94305 USA
Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA
Harvard Med Sch, McLean Hosp, Ctr Depress Anxiety & Stress Res, Belmont, MA 02478 USACalif State Univ Fresno, Dept Psychol, Fresno, CA 93740 USA
Sacchet, Matthew D.
Grill-Spector, Kalanit
论文数: 0引用数: 0
h-index: 0
机构:
Stanford Univ, Dept Psychol, Stanford, CA 94305 USA
Stanford Univ, Sch Med, Stanford Neurosci Inst, Stanford, CA 94305 USACalif State Univ Fresno, Dept Psychol, Fresno, CA 93740 USA
Grill-Spector, Kalanit
Gotlib, Ian H.
论文数: 0引用数: 0
h-index: 0
机构:
Stanford Univ, Dept Psychol, Stanford, CA 94305 USA
Stanford Univ, Sch Med, Stanford Neurosci Inst, Stanford, CA 94305 USACalif State Univ Fresno, Dept Psychol, Fresno, CA 93740 USA
机构:
Eli Lilly Asia Inc, Shanghai, Peoples R ChinaEli Lilly & Co, Lilly Res Labs, Toronto, ON M1N 2E8, Canada
Ang, Q. Q.
Wing, Y. K.
论文数: 0引用数: 0
h-index: 0
机构:
Chinese Univ Hong Kong, Shatin Hosp, Dept Psychiat, Hong Kong, Hong Kong, Peoples R ChinaEli Lilly & Co, Lilly Res Labs, Toronto, ON M1N 2E8, Canada
Wing, Y. K.
He, Y.
论文数: 0引用数: 0
h-index: 0
机构:
Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R ChinaEli Lilly & Co, Lilly Res Labs, Toronto, ON M1N 2E8, Canada
He, Y.
Sulaiman, A. H.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Malaya, Fac Med, Dept Psychol Med, Kuala Lumpur, MalaysiaEli Lilly & Co, Lilly Res Labs, Toronto, ON M1N 2E8, Canada
Sulaiman, A. H.
Chiu, N. -Y.
论文数: 0引用数: 0
h-index: 0
机构:
Changhua Christian Hosp, Dept Psychiat, Changhua, TaiwanEli Lilly & Co, Lilly Res Labs, Toronto, ON M1N 2E8, Canada
Chiu, N. -Y.
Shen, Y. -C.
论文数: 0引用数: 0
h-index: 0
机构:
Tzu Chi Gen Hosp & Univ, Dept Psychiat, Hualien, TaiwanEli Lilly & Co, Lilly Res Labs, Toronto, ON M1N 2E8, Canada
Shen, Y. -C.
Wang, G.
论文数: 0引用数: 0
h-index: 0
机构:
An Ding Hosp, Beijing, Peoples R ChinaEli Lilly & Co, Lilly Res Labs, Toronto, ON M1N 2E8, Canada
Wang, G.
Zhang, C.
论文数: 0引用数: 0
h-index: 0
机构:
Harbine First Spec Hosp, Harbin, Peoples R ChinaEli Lilly & Co, Lilly Res Labs, Toronto, ON M1N 2E8, Canada
Zhang, C.
Lee, K. -H.
论文数: 0引用数: 0
h-index: 0
机构:
Dongguk Univ Hosp, Gyeongju, South KoreaEli Lilly & Co, Lilly Res Labs, Toronto, ON M1N 2E8, Canada
Lee, K. -H.
Singh, P.
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly Australia Pty Ltd, Intercontinental Informat Sci, Sydney, NSW, AustraliaEli Lilly & Co, Lilly Res Labs, Toronto, ON M1N 2E8, Canada
Singh, P.
Granger, R. E.
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly Australia Pty Ltd, Intercontinental Informat Sci, Sydney, NSW, AustraliaEli Lilly & Co, Lilly Res Labs, Toronto, ON M1N 2E8, Canada
Granger, R. E.
Raskin, J.
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly & Co, Lilly Res Labs, Toronto, ON M1N 2E8, CanadaEli Lilly & Co, Lilly Res Labs, Toronto, ON M1N 2E8, Canada
Raskin, J.
Dossenbach, M.
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly GmbH, Vienna, AustriaEli Lilly & Co, Lilly Res Labs, Toronto, ON M1N 2E8, Canada
机构:
Eli Lilly Japan KK, Med Dev Unit Japan, Med Sci, Kobe, Hyogo 6510086, JapanEli Lilly Japan KK, Med Dev Unit Japan, Med Sci, Kobe, Hyogo 6510086, Japan
Harada, Eiji
Satoi, Yoichi
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly Japan KK, Stat Sci, Med Dev Unit Japan, Kobe, Hyogo 6510086, JapanEli Lilly Japan KK, Med Dev Unit Japan, Med Sci, Kobe, Hyogo 6510086, Japan
Satoi, Yoichi
Kikuchi, Toshiaki
论文数: 0引用数: 0
h-index: 0
机构:
Kyorin Univ, Sch Med, Dept Neuropsychiat, Mitaka, Tokyo, JapanEli Lilly Japan KK, Med Dev Unit Japan, Med Sci, Kobe, Hyogo 6510086, Japan
Kikuchi, Toshiaki
Watanabe, Koichiro
论文数: 0引用数: 0
h-index: 0
机构:
Kyorin Univ, Sch Med, Dept Neuropsychiat, Mitaka, Tokyo, JapanEli Lilly Japan KK, Med Dev Unit Japan, Med Sci, Kobe, Hyogo 6510086, Japan
Watanabe, Koichiro
Alev, Levent
论文数: 0引用数: 0
h-index: 0
机构:
Eli Lilly Japan KK, Med Dev Unit Japan, Med Sci, Kobe, Hyogo 6510086, JapanEli Lilly Japan KK, Med Dev Unit Japan, Med Sci, Kobe, Hyogo 6510086, Japan
Alev, Levent
Mimura, Masaru
论文数: 0引用数: 0
h-index: 0
机构:
Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, JapanEli Lilly Japan KK, Med Dev Unit Japan, Med Sci, Kobe, Hyogo 6510086, Japan
机构:
Kei Mental Clin, Med Fdn Keishin Kai, Omagari Torimachi 10-8, Daisen City, Akita 0140027, JapanKei Mental Clin, Med Fdn Keishin Kai, Omagari Torimachi 10-8, Daisen City, Akita 0140027, Japan
Sekine, Atsushi
Hozumi, Satoshi
论文数: 0引用数: 0
h-index: 0
机构:
Kyowa Hosp, Med Fdn Keishin Kai, Daisen City, Akita, JapanKei Mental Clin, Med Fdn Keishin Kai, Omagari Torimachi 10-8, Daisen City, Akita 0140027, Japan
Hozumi, Satoshi
Shimizu, Tetsuo
论文数: 0引用数: 0
h-index: 0
机构:
Akita Univ, Grad Sch Med, Dept Psychiat, Akita, Akita, JapanKei Mental Clin, Med Fdn Keishin Kai, Omagari Torimachi 10-8, Daisen City, Akita 0140027, Japan